EMA: Benefits of J&J Covid-19 vaccine outweigh risks The European Medicines Agency has said the benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks. Coronavirus • 20 Apr
J&J reports $100m in vaccine sales in first quarter Johnson & Johnson has today beaten expectations for quarterly revenue and profit and raised dividend payouts to shareholders. Business • 20 Apr
Johnson & Johnson delays European vaccine roll-out Johnson & Johnson has said it will delay the roll-out of its Covid-19 vaccine in Europe after US authorities moved to suspend use of the ... Coronavirus • 13 Apr
EMA to review blood clot link with J&J Covid-19 vaccine The EU's drug regulator has said it has launched a review of possible links between the Johnson & Johnson coronavirus vaccine and blood clots after ... Coronavirus • 09 Apr
J&J to deliver Covid-19 vaccine to Europe from 19 April Johnson & Johnson has said it would start delivering its single-shot Covid-19 vaccine to Europe on 19 April, giving the continent a boost as it ... Coronavirus • 29 Mar
One-shot J&J vaccine approved by EU drugs regulator The European Union's drugs regulator has recommended conditionally approving Johnson & Johnson's single dose Covid-19 vaccine. Coronavirus • 11 Mar
US to approve Johnson & Johnson Covid vaccine A US panel of independent experts has voted unanimously in favour of recommending Johnson & Johnson's one-dose Covid-19 shot for emergency approval. Coronavirus • 27 Feb
Johnson & Johnson promises 2021 profit jump Johnson & Johnson has today forecast 2021 profit above Wall Street estimates and promised data from its widely watched coronavirus vaccine trial soon. Business • 26 Jan
Johnson & Johnson pauses Covid vaccine trial Johnson & Johnson has temporarily halted its Covid-19 vaccine trial because one of its participants had become sick, the company said. Coronavirus • 13 Oct 20
J&J in deal for autoimmune disease specialist Moment Johnson & Johnson has today agreed to pay about $6.5 billion in cash to buy Momenta Pharmaceuticals in a deal aimed at expanding its portfolio ... Business • 19 Aug 20
Covid vaccine 'likely' to be available in 2021 - Fauci Drug companies will likely have tens of millions of doses of coronavirus vaccines in the early part of next year, with production ramping up to ... Coronavirus • 05 Aug 20
Prescription drugs boosts Johnson & Johnson forecasts Johnson & Johnson raised its full-year earnings forecast as it reported higher third-quarter sales of psoriasis treatment Stelara and cancer drug Imbruvica while attempting to ... Business • 15 Oct 19
US firm ordered to pay man $8bn over breast growth A Pennsylvania jury has ruled that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that ... World • 09 Oct 19
Purdue deal to rank among biggest in pharma history OxyContin maker Purdue Pharma LP has reached a tentative multibillion-dollar agreement with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in ... Business • 16 Sep 19
J&J boosted by better than expected pharma unit sales Johnson & Johnson beat quarterly profit estimates on higher sales at its pharmaceuticals unit even as it faces fierce competition for some of its biggest ... Business • 16 Apr 19
J&J shares drop 6% following report over asbestos Shares of Johnson & Johnson (J&J) fell over 6% after Reuters reported that the pharmaceutical company knew that its baby powder was contaminated with cancer-causing ... World • 14 Dec 18
Reversal of J&J $72m verdict over talc cancer risks Johnson & Johnson has won the reversal of a $72m (€61.3m) verdict in the US in favour of the family of a woman whose death ... Business • 18 Oct 17
J&J ordered to pay $417m in trial over talc cancer risk A US jury has ordered Johnson & Johnson to pay $417m to a woman who claimed she developed ovarian cancer after using the company's talc-based ... Business • 22 Aug 17
